Shengsheng Lai

机构：Guangdong Food and Drug Vocational College · ORCID：0009-0006-3194-5711

发表论文 48 篇 · 总被引 571 次 · h-index 13

代表论文

• Nanoparticle-mediated blockade of CXCL12/CXCR4 signaling enhances glioblastoma immunotherapy: Monitoring early responses with MRI radiomics (2024 · Acta Biomaterialia · 被引 43)
• Dual‐Modality Imaging‐Guided Manganese‐Based Nanotransformer for Enhanced Gas‐Photothermal Therapy Combined Immunotherapeutic Strategy Against Triple‐Negative Breast Cancer (2023 · Small · 被引 21)
• Immunity/metabolism dual-regulation via an acidity-triggered bioorthogonal assembly nanoplatform enhances glioblastoma immunotherapy by targeting CXCL12/CXCR4 and adenosine-A2AR pathways (2025 · Biomaterials · 被引 19)
• A subregion-based RadioFusionOmics model discriminates between grade 4 astrocytoma and glioblastoma on multisequence MRI (2024 · Journal of Cancer Research and Clinical Oncology · 被引 12)
• Noninvasive identification of proliferative hepatocellular carcinoma on multiphase dynamic CT: quantitative and LI-RADS lexicon-based evaluation (2024 · European Radiology · 被引 10)
• Quantitative Measurement on Contrast-Enhanced CT Distinguishes Small Clear Cell Renal Cell Carcinoma From Benign Renal Tumors: A Multicenter Study (2023 · Academic Radiology · 被引 7)